Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Team Novo Nordisk Confirm 18 Rider Roster for 2023 Season


News provided by

Team Novo Nordisk

Dec 05, 2022, 08:30 ET

Share this article

Share toX

Share this article

Share toX


Team Novo Nordisk, the world's first all diabetes professional cycling team, go into 2023 with an 18-rider roster

ATLANTA, Dec. 5, 2022 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all diabetes professional cycling team, go into 2023 with an 18-rider roster that combines youthful talent with experience and ready to take on their 13th season in the UCI pro ranks.

If 2021 was the season of frustration, then 2022 was the season of rediscovery and results. Top ten leading to the podium and the podium leading to victory.

“What pleased me the most this year was the team spirit and the togetherness. Now we approach 2023 with the same attitude and fundamentally the same team,” said Vassili Davidenko, TNN General Manager

Post this

At GP Kranj in Slovenia last July Andrea Peron achieved his lifelong dream of a professional win, demolishing the field of competition with an early attack towards the top of the final climb in central Kranj and exploding into the last 500m with nothing but focus and raw power pushing through the pedals, over the finish line and overcome with emotion.

2022 came together in that moment. A decade long career encapsulated in the final kilometer of a bike race. More than 500 million people living with diabetes around the world sharing what inspiration can look like and a community brought together with the joy of what is possible.

"What a season we had," began CEO & Co Founder Phil Southerland. "After the challenges of 2021, we started this year by telling the guys to get back to basics. Go out there and race with a smile on your face and above all have fun. Enjoy being here and use that enjoyment to channel the pressure of racing for results at the highest level of professional cycling."

"Guess what? It worked. Not only did we have our most consistent season ever in terms of results, our most consistent rider Andrea Peron, achieved his first career win in Slovenia at GP Kranj. After ten years of seconds, thirds, top five, top ten, and breakaways in monuments he kept pushing and banging on the door until he burst through. Diabetes didn't stop him, and neither could the competition and I don't think the future will either."

Only one change appears on the roster for 2023 with Uzbekistani climber Ulugbek Saidov returning to the TNN pro team after a season spent gaining experience and results racing for the Uzbekistan national team.

"We're very satisfied with our performances in 2022," said General Manager Vassili Davidenko. "To be sitting here reflecting on multiple podiums, top ten placings, and Andrea's win at GP Kranj feels like a good place to be, but also a place that we need to be more often. It's very important that we kick on in 2023 and carry the momentum from this year, there were many positive moments including Matyas (Kopecky) and Filippo (Ridolfo) starting their pro careers strongly and developing talents like Hamish (Beadle) beginning to show maturity and produce solid performances."

"But what pleased me the most was the team spirit and the togetherness, after such a difficult 2021 we could be forgiven for letting our heads drop, but we channeled that energy and used it as motivation. Now we approach 2023 with the same attitude and fundamentally the same team."

"We welcome back Ulugbek (Saidov) who has been on his own journey of development and is now ready to go again and play his part in helping the team. I'm excited to see what 2023 has in store and I'm sure that if we put the same hard work in then we are going to see more results and more smiles on our faces."

Once again the balance between experience and youthful talent will be important in 2023 with the older established captains Peron, Charles Planet, and David Lozano looking to bring on the younger riders as second year pro's Matyas Kopecky and Filippo Ridolfo look to repeat their positive debut seasons and push on to the next level.

Team Novo Nordisk for 2023:

Hamish Beadle (NZL, 24)

Sam Brand (GBR, 31)

Robbe Ceurens (BEL, 21)

Stephen Clancy (IRL, 30)

Lucas Dauge (FRA, 25)

Gerd de Keijzer (NLD, 28)

Jan Dunnewind (NLD, 24)

Joonas Henttala (FIN, 31)

Declan Irvine (AUS, 23)

Matyas Kopecky (CZE, 19)

Peter Kusztor (HUN, 37)

David Lozano (ESP, 33)

Andrea Peron (ITA, 34)

Logan Phippen (USA, 30)

Charles Planet (FRA, 29)

Umberto Poli (ITA, 26)

Filippo Ridolfo (ITA, 21)

Ulugbek Saidov (UZB, 26)

About Team Novo Nordisk – Racing to Drive Change in Diabetes
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate, and empower people around the world affected by diabetes and promote a healthy and active lifestyle. For more information, go to http://www.teamnovonordisk.com.

Image @TeamNovoNordisk

Media Contact

Tim Lindley, Team Novo Nordisk, +39 3911106499, [email protected]

SOURCE Team Novo Nordisk

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.